Like I said, appreciate you, appreciate you taking the time with us today
On April 29, 2025, a press release hailed the Novo Nordisk tie-up for "affordable access" to semaglutide, calling it "high-quality" and "personalized." Dudum said it tackled shortages while "prioritizing safety." The Q1 earnings call echoed this, with Dudum bragging about "innovative partnerships" for consumer choice
What to Expect With Semaglutide In contrast to one-size-fits-all approaches, we provide all patients with a custom plan tailored to their individual needs
Importantly, this is entirely optional
Latest developments in weight-loss drug lawsuits (2025) As of August 2025, more than 1,800 lawsuits have been filed against Novo Nordisk over Ozempic, Wegovy, and related GLP-1 drugs, with potential damages estimated to exceed $2 billion
It is designed to curb appetite and reduce cravings, aiding in weight management